Next Article in Journal
Human Cytomegalovirus Serostatus Defines Cytokine-Based Predictive Signatures in Sepsis
Next Article in Special Issue
Assessment of the Microbiological Quality of Raw Milk Sold Through Vending Machines at the Farm Level in Switzerland
Previous Article in Journal
Trends in Leishmaniasis: A 32-Year Review in an Endemic Area in the South of Madrid Region
Previous Article in Special Issue
Low Neutrophil Counts in Milk Are Associated with an Increased Frequency of Antimicrobial Treatments
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Dairy Farm Streptococcus agalactiae in a Region of Northeast Brazil: Genetic Diversity, Resistome, and Virulome

by
Vinicius Pietta Perez
1,*,
Fernanda Zani Manieri
2,
Luciana Roberta Torini
2,
Carlos Gabriel Andrade Barbosa
3,
Fabio Campioni
2,
Fabiana Caroline Zempulski Volpato
4,
Eloíza Helena Campana
3,
Artur Cezar de Carvalho Fernandes
5,
Afonso Luís Barth
4,
Eduardo Sergio Soares Sousa
6,
Celso Jose Bruno de Oliveira
5 and
Ilana Lopes Baratella da Cunha Camargo
2,*
1
Departamento de Microbiologia, Imunologia e Parasitologia, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Ramiro Barcelos Street 2600, Porto Alegre 90035-003, RS, Brazil
2
Laboratório de Epidemiologia e Microbiologia Moleculares—LEMiMo, Instituto de Física de São Carlos, Universidade de São Paulo, João Dagnone Avenue 1100, São Carlos 13563-120, SP, Brazil
3
Centro de Ciências da Saúde, Universidade Federal da Paraíba, Campus I. Cidade Universidade, João Pessoa 58051-900, PB, Brazil
4
Laboratório de Pesquisa em Resistência Bacteriana—LABRESIS, Hospital das Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Ramiro Barcelos Street 2350, Porto Alegre 90035-903, RS, Brazil
5
Centro de Ciências Agrárias, Universidade Federal da Paraíba, Campus II. Road PB 079, km 12, Areia 58397-000, PB, Brazil
6
Centro de Ciências Médicas, Universidade Federal da Paraíba, Campus I. Cidade Universidade, João Pessoa 58051-900, PB, Brazil
*
Authors to whom correspondence should be addressed.
Pathogens 2026, 15(2), 128; https://doi.org/10.3390/pathogens15020128
Submission received: 17 December 2025 / Revised: 14 January 2026 / Accepted: 16 January 2026 / Published: 24 January 2026

Abstract

Streptococcus agalactiae is a major cause of bovine mastitis, which affects the quality and yield of milk. The main strategy for controlling this pathogen on dairy farms is the use of antibiotics. This study investigated the clonality, serotype distribution, antimicrobial susceptibility, and presence of resistance and virulence genes in 46 S. agalactiae isolates obtained from raw bovine milk in northeastern Brazil. Capsular types were determined using multiplex PCR and antibiotic susceptibility profiles were determined using disc diffusion or the gradient strip method. Clonal diversity was evaluated via pulsed-field gel electrophoresis. Eight isolates were sequenced using short- and long-read methods. There was high overall genetic diversity, whereas the resistance and virulence profiles were largely homogeneous within herds. Tetracycline and macrolide resistance was frequent and mediated by tetO and ermB and less frequently by tetM. Genome analysis demonstrated that resistance genes are present in mobile genetic elements that are also present in human isolates, and phylogenomic analyses identified ST-103 as the predominant and multi-host-adapted lineage, whereas ST-91 clustered with the bovine-adapted lineage. These findings expand the molecular epidemiology of S. agalactiae in dairy farms of a region in northeast Brazil and highlight the importance of surveillance strategies for guiding mastitis control and mitigating the spread of antimicrobial resistance.

1. Introduction

In 1932, Rebecca Lancefield described two isolates obtained from bovine mastitis milk as Group B Streptococci, Streptococcus agalactiae [1]. Since then, this species has been associated with bovine mastitis. In Brazilian dairy herds, S. agalactiae remains the main agent of contagious mastitis, with the prevalence varying across regions and according to the characteristics of the dairy production system [2,3]. Contagious mastitis caused by S. agalactiae is strongly associated with intensive dairy production systems and the absence or inadequate implementation of mastitis control programs [2,4].
S. agalactiae is an intramammary pathogen in cattle, and its introduction into previously negative dairy farms is generally attributed to the acquisition of infected animals from other herds or, more recently, to its ability to survive in environmental sources [5]. Additionally, S. agalactiae is a commensal member of the human microbiota and an important cause of perinatal infections, including neonatal meningitis [6]. Some lineages have also been observed in other animals (fish, dolphins, dogs, rats, and frogs), and their zoonotic potential was highlighted in 2015 by an outbreak of bacteremia associated with the consumption of contaminated fish. Thus, S. agalactiae epidemiology should be considered within a One Health approach [7].
Several virulence factors contribute to its pathogenicity, such as the polysaccharide capsule playing a key role in immune evasion, fibrinogen-binding proteins (FbsA, FbsB, and FbsC) mediating adhesion to udder cells, hemolysin promoting cellular injury and invasion, and C5a peptidase encoded by scpB, recognized as an essential virulence determinant in human-adapted strains [8].
The use of antibiotics remains a primary strategy for controlling S. agalactiae in dairy farms. However, the widespread use of antimicrobials in veterinary medicine is a major driver of antimicrobial resistance [9]. Tetracycline (TET) resistance is common in S. agalactiae, estimated at 80.1% [10], mainly due to the acquisition of ribosomal protection proteins such as TetM, TetO, and TetS [11]. Additionally, resistance to macrolides, such as erythromycin (ERY), and lincosamides, such as clindamycin (CLI), globally estimated at 30.5% and 29.3%, mediated by 23S rRNA methyltransferases (erm genes) or efflux pumps, has emerged as a growing concern in recent years [10]. Resistance to beta-lactams, the first-line therapy, has also been reported in human and bovine mastitis strains [12,13]. These resistance trends highlight the need for the continuous surveillance of antimicrobial susceptibility in S. agalactiae to guide effective mastitis control strategies.
Epidemiological and genomic data on S. agalactiae in bovine milk from Northeast Brazil are scarce. In this study, we investigated the clonality, serotype distribution, antibiotic susceptibility profiles, presence of antibiotic resistance genes (ARGs), and virulence determinants in S. agalactiae isolates obtained from bulk tanks in four municipalities of Paraíba, Brazil. In addition, by integrating whole-genome sequencing (WGS) data generated using both short- and long-read platforms for eight representative isolates, we provide a deeper understanding of the population structure and genomic diversity of circulating S. agalactiae lineages.

2. Materials and Methods

2.1. Bacterial Isolation and Identification

This study included 46 S. agalactiae isolates that were obtained from raw bovine milk. Samples were collected from four bulk dairy farm tanks in Paraiba State, Brazil (Figure 1), from August 2018 to September 2022. Milk samples were collected under aseptic conditions and transported at 4–8 °C to subsequent microbiological analysis. Samples were inoculated onto blood agar plates supplemented with 5% sheep blood (HiMedia Laboratories, Mumbai, India) and incubated at 35 ± 1 °C for 24–72 h under aerobic conditions. Species-level identification was initially performed using conventional phenotypic methods, including catalase, Christie–Atkins–Munch–Petersen (CAMP), and L-pyrrolidonyl-β-naphthylamide (PYR) tests. Following preliminary identification, isolates were stored in Brain Heart Infusion (BHI) broth supplemented with 10% glycerol at −20 °C. Identification was subsequently confirmed by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry using the Biotyper 3.1 system (Bruker Daltonics, Bremen, Germany).

2.2. Antimicrobial Susceptibility Tests

The isolates were tested for susceptibility to penicillin (PEN), ERY, CLI, chloramphenicol (CHL), levofloxacin (LEV), linezolid (LZD), TET, and vancomycin (VAN) antibiotics using the disc-diffusion method (Cecon, São Paulo, Brazil) on Mueller-Hinton agar supplemented with 5% sheep blood (Newprov, Pinhais, Brazil) according to the Clinical and Laboratory Standard Institute (CLSI) [14]. The PEN minimum inhibitory concentration (MIC) was determined using the gradient strip method (E-test, Biomerieux, Marcy-l’Étoile, France) and evaluated according to the CLSI’s interpretive criteria [14].

2.3. Capsular Serotyping

The capsular type of each isolate (Ia, Ib, II, III, IV, V, VI, VII, VIII, and IX) was determined by multiplex polymerase chain reaction (PCR). Briefly, one colony of each isolate was transferred to a 10% Chelex-100 solution (Sigma-Aldrich, St. Louis, MO, USA), vortexed vigorously, and incubated in a dry bath at 95 °C for 30 min. The solution was then centrifuged at 4000 RPM for 30 s, and the supernatant was transferred to a microtube. Amplifications were performed in a total volume of 25 µL, in a MiniAmp thermal cycler (Applied Biosystems, Waltham, MA, USA), using five microliters of DNA in a multiplex PCR as previously described [15]. Additionally, the eight isolates selected for WGS (636, 659, 676, 690, 765, 782, 790, and 986) had their capsular types confirmed using the Group B Streptococcus (GBS) Typer pipeline (https://github.com/sanger-bentley-group/GBS-Typer-sanger-nf) accessed on 7 May 2024 [16].

2.4. Analysis of Clonality

Macrorestriction of chromosomal DNA using the SmaI enzyme (New England Biolabs, Ipswich, MA, USA), followed by pulsed-field gel electrophoresis (PFGE) was performed as previously described [6]. The run conditions were a 6 V/cm gradient, 23 h, 5 s initial switch time, and 35 s final switch time, using the CHEF Mapper system (Bio-Rad, Hercules, CA, USA). The gels were dyed with SYBR Safe DNA Gel Stain (Thermo Fisher Scientific, Waltham, MA, USA) and revealed using the ChemiDoc MP Imaging System (Bio-Rad, Hercules, CA, USA). The PFGE gel image was analyzed using Bionumerics software v. 7.6 (Applied Maths, Sint-Martens-Latem, Belgium) with 1.25% tolerance and 0.5% optimization.

2.5. Detection of Resistance and Virulence Genes

The ARGs (ermA/TR, ermB, mefA, tetM, and tetO genes) and virulence genes (cylB, fbsB, and scpB genes) were detected by PCR in all isolates. The DNA extraction was carried out as previously described for capsular serotyping. All amplifications were performed in a total volume of 20 µL, using a MiniAmp thermal cycler (Applied Biosystems, Waltham, MA, USA). Two microliters of DNA were added to a PCR reaction mix containing 0.20 µM of each primer (Table 1), 0.2 mM of each dNTP, 1 U Taq polymerase, 2 mM MgCl2, and reaction buffer 1X. The cycling parameters were as follows: 95 °C for 1 min, 35 cycles of 95 °C for 1 min, annealing for 1 min, extension at 72 °C for 1 min, and a final extension at 72 °C for 5 min (Table 1). The PCR product was run on a 2% agarose gel in Tris-acetate-EDTA buffer, stained with a UV nucleic acid stain (Sinapse Inc., São Paulo, Brazil), and visualized under a UV transilluminator. The results were evaluated based on the expected amplicon size (Table 1).

2.6. WGS and Bioinformatic Analysis

Eight isolates, selected to represent distinct clades identified in the clonality analysis, were randomly chosen for WGS. Sequencing was performed using a combination of short- and long-read technologies, following the methodologies previously described [6]. The obtained reads were assembled using Flye v.2.9.1 [20], with one polishing iteration, and hybrid assemblies were prepared using Polypolish v.0.5.0 [21]. Alternatively, the filtered long reads and trimmed short reads were assembled using Unicycler v.0.5.0 [22] and samtools v.1.15.1 [23], respectively, to compare the final assemblies. Graphical fragment assembly files were loaded into Bandage v.0.8.1 [24], and MLST v.2.22.0 [25] was used to determine sequence types (STs). The genomes were analyzed using the CGE service (https://www.genomicepidemiology.org/services) accessed on 7 May 2024, and mass screening of contigs for ARGs was performed using ABRicate v.1.0.19 (https://github.com/tseemann/abricate) accessed on 7 May 2024, and CARD RGI database v.3.2.7 [26]. BLASTn (https://blast.ncbi.nlm.nih.gov) was performed to identify the main virulence genes of S. agalactiae, and the pilus-coding genomic islands (PI-1A, PI-2A, and PI-2B) were determined using the GBS Typer pipeline [16] and manually checked in the hybrid-assembled genomes. The S. agalactiae Pathogenicity Islands (SagPAI) prediction was performed using GIPSy v.1.1.2 [27], and the results were manually curated according to Lannes-Costa et al. (2020) [28].
The sequenced genomes were assembled and annotated for phylogenomic analysis using Prokka v. 1.14.6 [29], and compared with Roary v. 3.13.0 [30]. The reference genomes NGBS128, 2603V/R, BM110, and MA12 (isolates from human hosts), and the 28 reference genomes from cow milk in Brazil, retrieved from the National Center for Biotechnology Information database (NCBI) on 5 December 2025 (Supplementary File S1), were annotated and loaded for comparison with this study’s isolates. A core genome phylogenetic tree was generated using IQ-TREE v2.0.7 [31] to infer the maximum likelihood and was visualized using FigTree v1.4.4 (https://tree.bio.ed.ac.uk/software/figtree) accessed on 30 November 2025.

3. Results

3.1. Bacterial Identification

In this study, a total of 91 bacterial isolates were obtained from bulk tank milk samples collected from four dairy farms located in the municipalities of Areia, Barra de Santana, Pilões, and Soledade, in the state of Paraíba, Brazil. Among these, 64 isolates showed typical colony morphology on blood agar, negative catalase and PYR test results, and a positive CAMP reaction. Species-level identification was confirmed by MALDI-TOF, which identified all 64 isolates as S. agalactiae, with confidence scores ranging from 1.80 to 2.41. Of these, 46 isolates were successfully recovered and preserved throughout all experimental procedures and were therefore included in the subsequent analyses.

3.2. Capsular Serotyping and PFGE Analysis

Of the 46 isolates included in this study, the most prevalent serotype was Ia (n = 24/46, 52.2%), followed by III (n = 21/46, 45.6%), and IV (n = 1/46, 2.2%). Macrorestriction of chromosomal DNA, followed by PFGE, clustered the isolates into 26 pulsotypes (Figure 2).

3.3. Antimicrobial Susceptibility and Detection of ARGs by PCR

All the isolates were susceptible to CHL, LEV, LZD, PEN, and VAN. The PEN MIC values ranged from 0.032 to 0.094 µg/mL, with MIC50 and MIC90 of 0.047 and 0.094 µg/mL, respectively. The highest resistance index was found for TET (n = 30/46, 65.2%), followed by CLI (n = 20/46, 43.5%), and ERY (n = 19/46, 41.3%) (Figure 2); one isolate was intermediate for ERY. CLI-resistant isolates showed a constitutive MLSb (resistance to macrolides, lincosamides, and streptogramin B) phenotype. The ermB (n = 20/46, 43.5%) and tetO (n = 20/46, 43.5%) genes were the most prevalent determinants of resistance, and the tetM gene was also reported (n = 8/46, 17.4%). None of the isolates harbored the ermA/TR or mefA genes (Table 2).

3.4. Detection of Virulence Genes by PCR

PCR detection of virulence genes revealed a high prevalence of cylB and fbsB among the S. agalactiae isolates. All isolates analyzed (n = 46/46, 100%) were positive for both genes (cylB and fbsB). In contrast, the scpB gene was detected in only a single isolate (isolate 1379), corresponding to a prevalence of 2.2% (Table 2).

3.5. Genomic Characterization of Representative S. agalactiae Isolates

Eight of the 46 isolates were selected for WGS based on their representation of distinct clades identified in the clonality analysis. These included four serotype Ia isolates (782, 790, 765, and 986), corresponding to pulsotypes 1a, 4b, 9a, and 24, and four serotype III isolates (659, 636, 676, and 690), corresponding to pulsotypes 11, 17, 18a, and 22, respectively.
Among the eight sequenced isolates, four were assigned to ST-103 (n = 4/8, 50%), three to ST-91 (n = 3/8, 37.5%), and one was a single-locus variant (SLV) of ST-91 (n = 1/8, 12.5%), characterized by a non-typeable glcK allele (Table 3).
Two isolates belonging to ST-91 and the SLV of ST-91 harbored the ARGs ant6-Ia, ermB, and tetO within a 60 kb genomic region exhibiting high homology to the clinical S. agalactiae isolate XM_1 (accession number CP147645). In isolate 676, contig 4 comprised 230 kb and showed 99% nucleotide identity with XM_1, with 88% genome coverage. Only isolate 676 contained a complete cyl operon (cylFEBAZCGDX), whereas isolates 690 and 636 displayed transposase and insertion sequence elements upstream of the ant6-Ia, ermB, and tetO genes. This contig also harbored genes encoding a plasmid relaxosome protein (MobC), a relaxase-domain-containing protein, several phage-related proteins, and the replication initiation protein RepA (Figure 3). Among the ST-103 isolates, only one carried an antimicrobial resistance gene (tetM).
The virulence profile was homogeneous according to STs. All isolates contained PI-2B, bca, cfb, cspA, cylE, fbsA, fbsB, fbsC, hylB, rib, sip, and pbsP. Only isolates of ST-103 carried the srr1 gene, and no sequenced isolate showed bac, scpB, lmb, or hvgA genes (Table 3).
The presence of complete or partial SagPAIs was investigated in the eight sequenced isolates by comparing their genomic profiles with those of the hypervirulent S. agalactiae ST-17 lineage, which is known to harbor 11 SagPAIs. SagPAI-11, which includes the scpB and lmb genes, was absent in all analyzed genomes. As shown in Figure 4, complete and partial SagPAIs were identified among the sequenced isolates. SagPAI-4 and SagPAI-8 were partially present in all isolates. Only isolate 659 harbored a complete SagPAI-5, whereas the remaining isolates contained this island only partially. SagPAI-2, which carries the Tn916 element and the tetM gene, was detected exclusively in isolate 790.
A maximum-likelihood phylogenetic tree was constructed using the eight isolates sequenced in this study together with genome sequences retrieved from the NCBI GenBank database (Figure 5). Core genome phylogenetic analysis revealed three major lineages among S. agalactiae isolates obtained from bovine milk in Brazil, with ST-103 representing the predominant lineage, followed by ST-91 and ST-67. These lineages were genetically distant from human-adapted pathogenic lineages, such as ST-17. The four ST-103 isolates from this study (765, 782, 790, and 986) clustered with previously reported ST-103 isolates from the same region, including one isolate obtained from a human host in 2021 (MA12) and one isolate recovered from bovine milk in 2021 (390C S7). The three ST-91 isolates and the SLV-ST91 isolate clustered with isolates from Minas Gerais (LGMAI_St_11 and LGMAI_St_14) and São Paulo (LGMAI_St_8) states.

4. Discussion

Bovine mastitis is primarily of infectious origin and often caused by S. agalactiae, resulting in substantial losses in productivity and milk quality [5]. Additionally, milk can serve as a reservoir for resistant pathogens and mobile genetic elements carrying resistance genes, which can be transmitted to humans and other animals [32].
This study describes the genetic profiles of 46 S. agalactiae isolates from dairy farms in northeastern Brazil, contributing to improved mastitis control programs and milk quality monitoring. Genetic diversity analysis of the four herds showed that among the 21 isolates from Herd A, 14 pulsotypes were identified, all serotype III, with high resistance rates to CLI, ERY, and TET (95.2%). In Herd B, 10 pulsotypes were observed among 23 serotype Ia isolates, of which nine (39%) exhibited resistance only to TET. The remaining two pulsotypes corresponded to one serotype IV isolate from Herd C, which was also resistant to TET, and one serotype Ia isolate from Herd D, which was susceptible to all tested antibiotics. S. agalactiae is a highly contagious pathogen that is well-adapted to the udder environment, enabling its rapid spread within herds and causing both clinical and subclinical mastitis. Furthermore, during outbreaks, environmental transmission cycles may occur, posing significant challenges for the effective eradication of specific strains in dairy farms [5]. Thus, we observed high genetic diversity but phenotypic homogeneity within each herd, suggesting the persistence and local dissemination of specific strains within the herds.
Capsular polysaccharides are the major virulence factors of S. agalactiae, with ten recognized serotypes (Ia, Ib, II, III, IV, V, VI, VII, VIII, and IX). A multicenter study reported serotype III as the most prevalent serotype in Brazilian dairy farms; however, the distribution of serotypes varies regionally, with serotypes II, Ia, and III being the most common in northeastern herds [33]. In Argentina, a recent study identified serotypes III, II, and Ia, each predominating on individual dairy farms [34]. In our study, the most prevalent serotypes were Ia (52.2%) and III (45.6%), followed by IV (2.2%), reinforcing the association between serotype distribution and geographical region.
Surveillance of antimicrobial resistance in S. agalactiae is essential for effective mastitis control programs. Beta-lactams are first-line agents for Streptococcus infections, and reduced susceptibility of S. agalactiae isolates from bovine milk has emerged as a concern [12]. Isolates with PEN MIC ≤ 0.12 μg/mL are considered susceptible; in our study, the PEN MIC90 was 0.094 μg/mL, indicating that beta-lactams remain effective against S. agalactiae in bovine milk in northeastern Brazil.
Despite the high effectiveness of beta-lactams, resistance to macrolides and lincosamides such as ERY and CLI has increased over the last decade, coinciding with their expanded use. A meta-analysis revealed substantial geographic variation in ERY resistance, with the lowest prevalence in the Americas (14.9%) and the highest in Asia (43.4%) [10]. Recent studies of pregnant women in Brazil have reported an increasing prevalence of ERY resistance in the community (from 11.4% to 42.1%) after the COVID-19 pandemic, mainly driven by the mefA gene and less frequently by ermA and ermB [35,36], whereas resistance to CLI remained stable. In our study, we observed high resistance rates to ERY (41.3%) and CLI (43.5%) associated with the ermB gene, which encodes a 23S rRNA methyltransferase that confers resistance to macrolides, lincosamides, and streptogramin B. Indeed, S. agalactiae isolates from bovine origin in Brazil have previously been associated with higher ERY resistance rates (27.6–29.1%) [37,38]. In Brazil, combinations of macrolides and aminoglycosides are among the most frequently used intramammary therapies for mastitis [9], and their widespread use has contributed to increasing resistance levels. It is important to highlight that CLI is a key second-line therapy [10], particularly in human medicine, and the dissemination of S. agalactiae strains harboring erm genes raises concerns regarding their future reliability.
Excessive use of TET as a prophylactic agent or growth promoter in the past has led to high levels of resistance in S. agalactiae, primarily driven by ribosomal protection genes such as tetM and tetO [38]. The tetM gene, which is typically associated with the Tn916 transposon family, is a characteristic feature of human-adapted strains and is less frequently found in bovine mastitis isolates. In contrast, tetO is the most common determinant in bovine strains [6,34]. In our study, TET resistance was the most frequent antibiotic-resistant phenotype. Among the resistant isolates, tetO was the predominant determinant, accounting for two-thirds of TET-resistant isolates, whereas tetM was detected in 26.7% of isolates. Furthermore, two isolates did not exhibit any of the tested resistance mechanisms, suggesting that other genotypes, such as tetS, tetL, or tetT, may be related to TET resistance in our setting [11].
Regarding ARGs, the combination of ermB and tetO was the most frequent genotype (43.5%) detected exclusively in serotype III isolates from a single herd (municipality A). A high prevalence of tetO and ermB has also been reported in Argentine herds, possibly associated with horizontally transferred genetic elements [34]. To further investigate this issue, we examined the genetic context of ARGs in three of these isolates (636, 676, and 690), identified as ST-91 or SLV of ST-91, and detected a genomic region with high similarity to that of an invasive S. agalactiae strain from the clonal complex (CC) 17 isolated in China (Figure 3). Moreover, the presence of tetO and ermB within a variant of the integrative conjugative element ICESag37 has been reported as a characteristic feature of two Brazilian clusters of ST-103 bovine strains [39]. These findings suggest that ARGs are integrated into the chromosomes of these isolates, supporting the possibility of the horizontal transfer of these resistance determinants among distinct S. agalactiae lineages.
Fibrinogen-binding proteins promote adherence to epithelial cells and are encoded by the fbsA/B/C gene family; fbsB is also associated with host cell invasion [8]. The cytolysin pigment, involved in cell invasion, tissue damage, and antioxidant activity, is encoded by the cyl operon, which comprises 12 genes, including cylB and cylE [40]. The scpB gene encodes C5a peptidase, an enzyme that inactivates the human complement factor C5a and plays a key role in adhesion and invasion in human-associated strains; however, it is less frequently observed in bovine isolates [8,40]. Regarding the prevalence of virulence genes, PCR detection of cylB, fbsB, and scpB demonstrated a homogeneous profile among isolates from the Paraíba herds. Only one isolate (2.2%) harbored scpB. For comparison, a study in Poland reported a prevalence of 35.3% [8], whereas no scpB was detected among ST-103 strains in Brazil [39]. The low prevalence of the scpB gene observed here suggests that S. agalactiae circulating in Paraíba herds may pose a reduced risk of invasive infections following transmission to humans.
Among the eight sequenced isolates, a broad repertoire of virulence factors was identified. These include srr, which is associated with epithelial cell adhesion; cfb and bca, which are related to tissue and cell injury; and pbsP and hylB, which are implicated in tissue invasion. Additional genes, such as cspA, hylB, sip, rib, and bac, have been identified and are known to interfere with host immune response mechanisms. Pili expression, which is an important determinant of persistent colonization and biofilm formation, was also observed in this study. S. agalactiae carries two pilus island variants (PI-1 and PI-2), and the PI-2B variant is considered characteristic of bovine-adapted strains [6]. Overall, the virulence gene profiles were largely homogeneous, differing only in the presence of srr1, which was exclusively detected in ST-103 isolates. As previously reported, srr1 is a common feature of ST-103 strains obtained from both bovine and human hosts [39].
The SagPAI profiles revealed a reduced repertoire in ST-91 isolates compared with ST-103 isolates. Furthermore, our findings are consistent with those of previous studies that reported low conservation of several SagPAIs (2, 4, 5, and 8) across sequenced genomes. Additionally, we observed the absence of SagPAI-11, which contains scpB and lmb genes that are strongly associated with human-invasive isolates rather than bovine strains [6,28].
Phylogenetic analysis of the eight sequenced isolates from this study, together with genomes retrieved from the NCBI database, revealed the evolutionary relationships of S. agalactiae from bovine milk in Brazil, highlighting the clear evolutionary separation between human-specialized (CC17) and bovine-specialized lineages. The STs identified in this study (ST-91 and ST-103) have been previously reported in Brazilian dairy herds [33]. In the phylogenetic tree, ST-91 and ST-67 appeared to be most closely related, likely sharing a genetic background relevant to host adaptation, in contrast to ST-103. Indeed, clonal complex CC61/67 has never been reported in human hosts and is considered specialized for colonization of the bovine mammary gland, possibly driven by pseudogenization of the cps operon, which encodes the polysaccharide capsule; these CCs have been nearly eliminated from European herds [4]. In contrast, ST-103 was the most frequent lineage among the isolates in this study and across the NCBI-retrieved genomes. ST-103 is an important host generalist lineage in several countries, including Brazil [4,39]. Notably, one genome sequence (MA12), previously obtained from a human patient in Paraíba, Brazil [6], clustered with ST-103 isolates from this study. This finding underscores the potential for the inter-host transmission of ST-103.
Despite the relevance of these findings, some limitations must be considered when interpreting our conclusions. The isolates were obtained from only four municipalities in Paraíba, northeastern Brazil; therefore, the results cannot be extrapolated to other regions or production systems. The limited number of sequenced isolates also restricts their ability to fully capture existing genomic and population variability. In addition, the study did not include data on farm management practices, interventions, or antibiotic use, which could have influenced the introduction, persistence, and adaptation of specific lineages. Finally, further studies with broader geographic coverage and expanded sampling are necessary to confirm and refine these observations across the different regions of Brazil.

5. Conclusions

Forty-six S. agalactiae isolates obtained from bulk tanks in northeastern Brazil were investigated. PFGE revealed high overall genetic diversity; however, virulence and resistance profiles were largely homogeneous within each herd, reinforcing the contagious nature of S. agalactiae and its local dissemination pattern. Antimicrobial resistance was common and was primarily driven by tetO and ermB genes. WGS demonstrated that these resistance determinants were integrated into the mobile genetic elements found in human clinical isolates. Additionally, ST-103 was the most prevalent lineage, and phylogenetic analyses highlighted its multihost-adapted status, whereas ST-91 clustered with the bovine-adapted CC61/67 complex. Together, these findings expand the molecular epidemiological understanding of S. agalactiae on northeastern Brazilian dairy farms and support the development of improved mastitis control strategies and milk quality management practices.

Supplementary Materials

The following supporting information can be downloaded from https://www.mdpi.com/article/10.3390/pathogens15020128/s1. File S1: List of reference strains retrieved from the NCBI database; File S2: General information and accession numbers of sequenced isolates; File S3: Pathogenicity islands report in the sequenced isolates.

Author Contributions

Conceptualization: V.P.P., E.H.C., and I.L.B.d.C.C.; Methodology and investigation: L.R.T., C.G.A.B., F.C.Z.V., E.S.S.S., F.C., A.C.d.C.F., and F.Z.M.; Data curation and formal analysis: F.Z.M., L.R.T., and C.G.A.B.; Resources: A.L.B. and C.J.B.d.O.; Writing—original draft preparation: V.P.P., F.Z.M., E.H.C., I.L.B.d.C.C.; Writing—review and critical editing: V.P.P., L.R.T., C.G.A.B., F.C.Z.V., E.S.S.S., F.C., A.C.d.C.F., F.Z.M., I.L.B.d.C.C., A.L.B., and C.J.B.d.O.; Funding acquisition: V.P.P., E.S.S.S., and I.L.B.d.C.C. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by grants from 270/2020 Paraiba State Research Foundation (FAPESQ), 2019/23684-9 and 2022/14323-5 São Paulo Research Foundation (FAPESP). I.L.B.d.C.C was supported by a fellowship from the National Council for Scientific and Technological Development (CNPq) Research Productivity Scholar, level 2, grant #304325/2021-0. C.J.B.d.O holds a level 1A productivity scholarship from the National Council for Scientific and Technological Development (CNPq. 304924/2025-3). The Illumina Miseq sequencing platform has been supported by CT-INFRA (FINEP/MCT). The APC was funded by a grant 3043/2021 from the Paraiba State Research Foundation (FAPESQ).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions of this study are included in the article/supplementary materials. The assembly files and annotated genomes are available on the NCBI database (accession numbers available on Supplementary File S2). Raw sequencing data (Illumina and Nanopore files) and further inquiries can be directed to the corresponding author.

Acknowledgments

We are thankful to Laboratório de Avaliação de Produtos de Origem Animal (LAPOA/CCA/UFPB) for the short-read sequencing on the Illumina platform, and to the authors and to sequencing centers that deposited the Streptococcus agalactiae genome sequences in the NCBI database: Oliveira, L.M.A. and Pinto, T.C.A from Universidade Federal do Rio de Janeiro; Vidal Amaral, J.R.; Juca Ramos, R.T.; Almeida Araujo, F.; Bentes Kato, R.; Figueira Aburjaile, F., de Castro Soares, S., Goes-Neto, A., Matiuzzi da Costa, M., Azevedo, V., Brenig, B., Soares de Oliveira, S., and Soares Rosado, A., from Universidade Federal do Rio de Janeiro; and Silva, N.C.C. and Morasi, R.M., from UNICAMP.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
ARGAntibiotic resistance gene
CCClonal complex
CHLChloramphenicol
CLIClindamycin
CLSIClinical Laboratory Standard Institute
ERYErythromycin
LEVLevofloxacin
LZDLinezolid
MGEMobile genetic element
MICMinimum inhibitory concentration
MLSbResistance to macrolides, lincosamides and streptogramin B
NCBINational Center for Biotechnology Institute
PCRPolymerase chain reaction
PENPenicillin
PFGEPulsed-field gel electrophoresis
PIPilus island
SLVSingle locus variant
STSequence type
TETTetracycline
VANVancomycin
WGSWhole-genome sequencing

References

  1. Lancefield, R.C. A serological differentiation of human and other groups of hemolytic streptococci. J. Exp. Med. 1933, 57, 571–595. [Google Scholar] [CrossRef] [PubMed]
  2. Oliveira, C.S.F.; Hogeveen, H.; Botelho, A.M.; Maia, P.V.; Coelho, S.G.; Haddad, J.P.A. Cow-Specific Risk Factors for Clinical Mastitis in Brazilian Dairy Cattle. Prev. Vet. Med. 2015, 121, 297–305. [Google Scholar] [CrossRef]
  3. de Oliveira, R.P.; Aragão, B.B.; de Melo, R.P.B.; da Silva, D.M.S.; de Carvalho, R.G.; Juliano, M.A.; Farias, M.P.O.; de Lira, N.S.C.; Mota, R.A. Bovine Mastitis in Northeastern Brazil: Occurrence of Emergent Bacteria and Their Phenotypic and Genotypic Profile of Antimicrobial Resistance. Comp. Immunol. Microbiol. Infect. Dis. 2022, 85, 101802. [Google Scholar] [CrossRef] [PubMed]
  4. Crestani, C.; Forde, T.L.; Lycett, S.J.; Holmes, M.A.; Fasth, C.; Persson-Waller, K.; Zadoks, R.N. The Fall and Rise of Group B Streptococcus in Dairy Cattle: Reintroduction Due to Human-to-Cattle Host Jumps? Microb. Genom. 2021, 7, 000648. [Google Scholar] [CrossRef]
  5. Barsi, F.; Carra, E.; Ricchi, M.; Gnali, G.; Pisoni, G.; Russo, S.; Filippi, A.; Arrigoni, N.; Zadoks, R.N.; Garbarino, C. Circulation of Streptococcus agalactiae ST103 in a Free Stall Italian Dairy Farm. Appl. Environ. Microbiol. 2022, 88, e00383-22. [Google Scholar] [CrossRef]
  6. Perez, V.P.; Torini, L.R.; Manieri, F.Z.; de Queiroz, S.B.; de Brito Gomes, J.I.A.; Santos Filho, L.; Campana, E.H.; de Oliveira, C.J.B.; Sousa, E.S.S.; Camargo, I.L.B.C. Genomic Diversity, Virulome, and Resistome of Streptococcus agalactiae in Northeastern Brazil: Are Multi-Host Adapted Strains Rising? Pathogens 2025, 14, 292. [Google Scholar] [CrossRef]
  7. Oliveira, L.M.A.; Simões, L.C.; Costa, N.S.; Zadoks, R.N.; Pinto, T.C.A. The Landscape of Antimicrobial Resistance in the Neonatal and Multi-Host Pathogen Group B Streptococcus: Review from a One Health Perspective. Front. Microbiol. 2022, 13, 943413. [Google Scholar] [CrossRef]
  8. Zastempowska, E.; Twarużek, M.; Grajewski, J.; Lassa, H. Virulence Factor Genes and Cytotoxicity of Streptococcus agalactiae Isolated from Bovine Mastitis in Poland. Microbiol. Spectr. 2022, 10, e02224-21. [Google Scholar] [CrossRef] [PubMed]
  9. Tomazi, T.; Dos Santos, M.V. Antimicrobial Use for Treatment of Clinical Mastitis in Dairy Herds from Brazil and Its Association with Herd-Level Descriptors. Prev. Vet. Med. 2020, 176, 104937. [Google Scholar] [CrossRef]
  10. Hsu, C.-Y.; Moradkasani, S.; Suliman, M.; Uthirapathy, S.; Zwamel, A.H.; Hjazi, A.; Vashishth, R.; Beig, M. Global Patterns of Antibiotic Resistance in Group B Streptococcus: A Systematic Review and Meta-Analysis. Front. Microbiol. 2025, 16, 1541524. [Google Scholar] [CrossRef]
  11. Metcalf, B.J.; Chochua, S.; Gertz, R.E.; Hawkins, P.A.; Ricaldi, J.; Li, Z.; Walker, H.; Tran, T.; Rivers, J.; Mathis, S.; et al. Short-Read Whole Genome Sequencing for Determination of Antimicrobial Resistance Mechanisms and Capsular Serotypes of Current Invasive Streptococcus agalactiae Recovered in the USA. Clin. Microbiol. Infect. 2017, 23, 574.e7–574.e14. [Google Scholar] [CrossRef] [PubMed]
  12. Hu, Y.; Kan, Y.; Zhang, Z.; Lu, Z.; Li, Y.; Leng, C.; Ji, J.; Song, S.; Shi, H. New Mutations of Penicillin-Binding Proteins in Streptococcus agalactiae Isolates from Cattle with Decreased Susceptibility to Penicillin. Microb. Drug Resist. 2018, 24, 1236–1241. [Google Scholar] [CrossRef]
  13. Moroi, H.; Kimura, K.; Kotani, T.; Tsuda, H.; Banno, H.; Jin, W.; Wachino, J.-I.; Yamada, K.; Mitsui, T.; Yamashita, M.; et al. Isolation of Group B Streptococcus with Reduced β-Lactam Susceptibility from Pregnant Women. Emerg. Microbes Infect. 2019, 8, 2–7. [Google Scholar] [CrossRef]
  14. CLSI. Performance Standards for Antimicrobial Susceptibility Testing, 32nd ed.; Clinical and Laboratory Standard Institute: Wayne, PA, USA, 2022. [Google Scholar]
  15. Imperi, M.; Pataracchia, M.; Alfarone, G.; Baldassarri, L.; Orefici, G.; Creti, R. A Multiplex PCR Assay for the Direct Identification of the Capsular Type (Ia to IX) of Streptococcus agalactiae. J. Microbiol. Methods 2010, 80, 212–214. [Google Scholar] [CrossRef] [PubMed]
  16. Sanger-Bentley-Group/GBS-Typer-Sanger-Nf 2024: A Nextflow Pipeline for Streptococcus Agalactiae Genotyping. GitHub Repository. 2024. Available online: https://github.com/sanger-bentley-group/GBS-Typer-sanger-nf (accessed on 7 May 2024).
  17. Bobadilla, F.J.; Novosak, M.G.; Cortese, I.J.; Delgado, O.D.; Laczeski, M.E. Prevalence, Serotypes and Virulence Genes of Streptococcus agalactiae Isolated from Pregnant Women with 35–37 Weeks of Gestation. BMC Infect. Dis. 2021, 21, 73. [Google Scholar] [CrossRef] [PubMed]
  18. Pérez-Trallero, E.; Montes, M.; Orden, B.; Tamayo, E.; García-Arenzana, J.M.; Marimón, J.M. Phenotypic and Genotypic Characterization of Streptococcus pyogenes Isolates Displaying the MLSB Phenotype of Macrolide Resistance in Spain, 1999 to 2005. Antimicrob. Agents Chemother. 2007, 51, 1228–1233. [Google Scholar] [CrossRef] [PubMed]
  19. Poyart, C.; Jardy, L.; Quesne, G.; Berche, P.; Trieu-Cuot, P. Genetic Basis of Antibiotic Resistance in Streptococcus agalactiae Strains Isolated in a French Hospital. Antimicrob. Agents Chemother. 2003, 47, 794–797. [Google Scholar] [CrossRef] [PubMed]
  20. Kolmogorov, M.; Yuan, J.; Lin, Y.; Pevzner, P.A. Assembly of Long, Error-Prone Reads Using Repeat Graphs. Nat. Biotechnol. 2019, 37, 540–546. [Google Scholar] [CrossRef] [PubMed]
  21. Wick, R.R.; Holt, K.E. Polypolish: Short-Read Polishing of Long-Read Bacterial Genome Assemblies. PLoS Comput. Biol. 2022, 18, e1009802. [Google Scholar] [CrossRef] [PubMed]
  22. Wick, R.R.; Judd, L.M.; Gorrie, C.L.; Holt, K.E. Unicycler: Resolving Bacterial Genome Assemblies from Short and Long Sequencing Reads. PLoS Comput. Biol. 2017, 13, e1005595. [Google Scholar] [CrossRef]
  23. Li, H.; Handsaker, B.; Wysoker, A.; Fennell, T.; Ruan, J.; Homer, N.; Marth, G.; Abecasis, G.; Durbin, R. 1000 Genome Project Data Processing Subgroup. The Sequence Alignment/Map Format and SAMtools. Bioinformatics 2009, 25, 2078–2079. [Google Scholar] [CrossRef]
  24. Wick, R.R.; Schultz, M.B.; Zobel, J.; Holt, K.E. Bandage: Interactive Visualization of de Novo Genome Assemblies. Bioinformatics 2015, 31, 3350–3352. [Google Scholar] [CrossRef]
  25. Jolley, K.A.; Bray, J.E.; Maiden, M.C.J. Open-Access Bacterial Population Genomics: BIGSdb Software, the PubMLST.Org Website and Their Applications. Wellcome Open Res. 2018, 3, 124. [Google Scholar] [CrossRef]
  26. Alcock, B.P.; Huynh, W.; Chalil, R.; Smith, K.W.; Raphenya, A.R.; Wlodarski, M.A.; Edalatmand, A.; Petkau, A.; Syed, S.A.; Tsang, K.K.; et al. CARD 2023: Expanded Curation, Support for Machine Learning, and Resistome Prediction at the Comprehensive Antibiotic Resistance Database. Nucleic Acids Res. 2023, 51, D690–D699. [Google Scholar] [CrossRef]
  27. Soares, S.C.; Geyik, H.; Ramos, R.T.J.; de Sá, P.H.C.G.; Barbosa, E.G.V.; Baumbach, J.; Figueiredo, H.C.P.; Miyoshi, A.; Tauch, A.; Silva, A.; et al. GIPSy: Genomic Island Prediction Software. J. Biotechnol. 2016, 232, 2–11. [Google Scholar] [CrossRef]
  28. Lannes-Costa, P.S.; Baraúna, R.A.; Ramos, J.N.; Veras, J.F.C.; Conceição, M.V.R.; Vieira, V.V.; de Mattos-Guaraldi, A.L.; Ramos, R.T.J.; Doran, K.S.; Silva, A.; et al. Comparative Genomic Analysis and Identification of Pathogenicity Islands of Hypervirulent ST-17 Streptococcus agalactiae Brazilian Strain. Infect. Genet. Evol. 2020, 80, 104195. [Google Scholar] [CrossRef] [PubMed]
  29. Seemann, T. Prokka: Rapid Prokaryotic Genome Annotation. Bioinformatics 2014, 30, 2068–2069. [Google Scholar] [CrossRef] [PubMed]
  30. Page, A.J.; Cummins, C.A.; Hunt, M.; Wong, V.K.; Reuter, S.; Holden, M.T.G.; Fookes, M.; Falush, D.; Keane, J.A.; Parkhill, J. Roary: Rapid Large-Scale Prokaryote Pan Genome Analysis. Bioinformatics 2015, 31, 3691–3693. [Google Scholar] [CrossRef]
  31. Minh, B.Q.; Schmidt, H.A.; Chernomor, O.; Schrempf, D.; Woodhams, M.D.; von Haeseler, A.; Lanfear, R. IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era. Mol. Biol. Evol. 2020, 37, 1530–1534. [Google Scholar] [CrossRef] [PubMed]
  32. Oliver, J.P.; Gooch, C.A.; Lansing, S.; Schueler, J.; Hurst, J.J.; Sassoubre, L.; Crossette, E.M.; Aga, D.S. Invited Review: Fate of Antibiotic Residues, Antibiotic-Resistant Bacteria, and Antibiotic Resistance Genes in US Dairy Manure Management Systems. J. Dairy Sci. 2020, 103, 1051–1071. [Google Scholar] [CrossRef] [PubMed]
  33. Carvalho-Castro, G.A.; Silva, J.R.; Paiva, L.V.; Custódio, D.A.C.; Moreira, R.O.; Mian, G.F.; Prado, I.A.; Chalfun-Junior, A.; Costa, G.M. Molecular Epidemiology of Streptococcus agalactiae Isolated from Mastitis in Brazilian Dairy Herds. Braz. J. Microbiol. 2017, 48, 551–559. [Google Scholar] [CrossRef] [PubMed]
  34. Gerez, G.; Hernandez, L.B.; Cadona, J.; Sanso, A.M.; Bustamante, A.V. Genetic Diversity of Streptococcus agalactiae from Dairy Cattle with Mastitis in Argentina. BMC Vet. Res. 2025, 21, 338. [Google Scholar] [CrossRef] [PubMed]
  35. Barros, R.R.; Barros, C.C.; Kegele, F.C.O.; Francisca da S N Soares, M.; de Paula, G.R. Macrolide Resistance among Streptococcus agalactiae during COVID-19 Public Health Emergency in Brazil. Braz. J. Microbiol. 2024, 55, 1445–1449. [Google Scholar] [CrossRef]
  36. Gomes, J.I.A.d.B.; Queiroz, S.B.d.; Barbosa, C.G.A.; Silva, L.R.S.; Lundgren, P.U.; Sousa, E.S.S.; Campana, E.H.; Perez, V.P. Evolving Antimicrobial Resistance Patterns in Group B Streptococci: A Five-Year Study in a High-Risk Pregnancy Referral Center in Northeastern Brazil. Rev. Soc. Bras. Med. Trop. 2026, 59, e259, in press. [Google Scholar] [CrossRef]
  37. Dutra, V.G.; Alves, V.M.; Olendzki, A.N.; Dias, C.A.; de Bastos, A.F.; Santos, G.O.; de Amorin, E.L.; Sousa, M.Â.; Santos, R.; Ribeiro, P.C.; et al. Streptococcus agalactiae in Brazil: Serotype Distribution, Virulence Determinants and Antimicrobial Susceptibility. BMC Infect. Dis. 2014, 14, 323. [Google Scholar] [CrossRef] [PubMed]
  38. Tomazi, T.; de Souza Filho, A.F.; Heinemann, M.B.; Dos Santos, M.V. Molecular Characterization and Antimicrobial Susceptibility Pattern of Streptococcus agalactiae Isolated from Clinical Mastitis in Dairy Cattle. PLoS ONE 2018, 13, e0199561. [Google Scholar] [CrossRef]
  39. Oliveira, L.M.A.; Simões, L.C.; Crestani, C.; Costa, N.S.; Pantoja, J.C.F.; Rabello, R.F.; Fracalanzza, S.E.L.; Teixeira, L.M.; Khan, U.B.; Jamrozy, D.; et al. Group B Streptococcus Sequence Type 103 as Human and Bovine Pathogen, Brazil. Emerg. Infect. Dis. 2024, 30, 1697–1701. [Google Scholar] [CrossRef]
  40. Megli, C.J.; Carlin, S.M.; Giacobe, E.J.; Hillebrand, G.H.; Hooven, T.A. Virulence and Pathogenicity of Group B Streptococcus: Virulence Factors and Their Roles in Perinatal Infection. Virulence 2025, 16, 2451173. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Municipalities in the state of Paraíba, Brazil, where the dairy farms were located, and the 46 S. agalactiae isolates were obtained from bovine milk between 2018 and 2022. Including 21 isolates from Areia herd, 23 isolates from Barra de Santana herd, and from Pilões and Soledade one isolate of each herd. The yellow color indicates the state of Paraíba, and the orange color indicates the municipalities included in the study.
Figure 1. Municipalities in the state of Paraíba, Brazil, where the dairy farms were located, and the 46 S. agalactiae isolates were obtained from bovine milk between 2018 and 2022. Including 21 isolates from Areia herd, 23 isolates from Barra de Santana herd, and from Pilões and Soledade one isolate of each herd. The yellow color indicates the state of Paraíba, and the orange color indicates the municipalities included in the study.
Pathogens 15 00128 g001
Figure 2. Dendrogram showing genetic similarity among 46 S. agalactiae isolates from dairy farms in Paraiba, Brazil, between 2018 and 2022, generated using Bionumerics software v. 7. 1 (Applied Maths, Belgium). A dendrogram was generated using 1.25% tolerance and 0.5% optimization. CLI: clindamycin; CHL: chloramphenicol; ERY: erythromycin; LEV: levofloxacin; LZD: linezolid; PEN: penicillin; TET: tetracycline; VAN: vancomycin; S: susceptible; I: intermediate; R: resistant.
Figure 2. Dendrogram showing genetic similarity among 46 S. agalactiae isolates from dairy farms in Paraiba, Brazil, between 2018 and 2022, generated using Bionumerics software v. 7. 1 (Applied Maths, Belgium). A dendrogram was generated using 1.25% tolerance and 0.5% optimization. CLI: clindamycin; CHL: chloramphenicol; ERY: erythromycin; LEV: levofloxacin; LZD: linezolid; PEN: penicillin; TET: tetracycline; VAN: vancomycin; S: susceptible; I: intermediate; R: resistant.
Pathogens 15 00128 g002
Figure 3. BLAST alignment of a genome region of three S. agalactiae isolates obtained from bovine raw milk in Paraíba, Brazil, between 2018 and 2022, and isolate XM_1 (accession number CP147645) from China. The aligned regions correspond to positions from 370,000 to 500,000 of isolate XM_1, contig 4 of isolate 676, contig 79 of isolate 636, and contig 9 of isolate 690. Arrows represent predicted coding sequences (genes), with their orientation indicating the direction of transcription. Gray blocks indicate regions of nucleotide similarity identified by BLASTn, with color intensity reflecting the degree of sequence identity. Comparative analysis was performed using BLASTn (https://blast.ncbi.nlm.nih.gov) and Easyfig version 2.2.
Figure 3. BLAST alignment of a genome region of three S. agalactiae isolates obtained from bovine raw milk in Paraíba, Brazil, between 2018 and 2022, and isolate XM_1 (accession number CP147645) from China. The aligned regions correspond to positions from 370,000 to 500,000 of isolate XM_1, contig 4 of isolate 676, contig 79 of isolate 636, and contig 9 of isolate 690. Arrows represent predicted coding sequences (genes), with their orientation indicating the direction of transcription. Gray blocks indicate regions of nucleotide similarity identified by BLASTn, with color intensity reflecting the degree of sequence identity. Comparative analysis was performed using BLASTn (https://blast.ncbi.nlm.nih.gov) and Easyfig version 2.2.
Pathogens 15 00128 g003
Figure 4. Comparative analysis of the presence of the 11 SagPAIs described in the hypervirulent S. agalactiae ST-17 lineage among eight representative S. agalactiae isolates obtained from dairy farms in Paraíba, Brazil, between 2018 and 2022.
Figure 4. Comparative analysis of the presence of the 11 SagPAIs described in the hypervirulent S. agalactiae ST-17 lineage among eight representative S. agalactiae isolates obtained from dairy farms in Paraíba, Brazil, between 2018 and 2022.
Pathogens 15 00128 g004
Figure 5. Genome phylogeny of S. agalactiae isolates from bovine milk in Brazil and reference strains retrieved from the NCBI GenBank database. Blue labels indicate the isolates sequenced in this study, obtained from dairy herds in Paraíba between 2018 and 2022. Black labels represent reference sequences from bovine milk in Brazil retrieved from the NCBI database, whereas red labels represent reference sequences obtained from human hosts and retrieved from the NCBI database. Node values indicate bootstrap support. CC: clonal complex.
Figure 5. Genome phylogeny of S. agalactiae isolates from bovine milk in Brazil and reference strains retrieved from the NCBI GenBank database. Blue labels indicate the isolates sequenced in this study, obtained from dairy herds in Paraíba between 2018 and 2022. Black labels represent reference sequences from bovine milk in Brazil retrieved from the NCBI database, whereas red labels represent reference sequences obtained from human hosts and retrieved from the NCBI database. Node values indicate bootstrap support. CC: clonal complex.
Pathogens 15 00128 g005
Table 1. Oligonucleotide primer sequences for PCR assays to detect resistance and virulence genes in S. agalactiae from dairy farms in Paraiba, Brazil, between 2018 and 2022.
Table 1. Oligonucleotide primer sequences for PCR assays to detect resistance and virulence genes in S. agalactiae from dairy farms in Paraiba, Brazil, between 2018 and 2022.
TargetSequence
(5′–3′)
Size
(bp)
Annealing Temperature (°C)
cylB [17]GGGCTGCAGGTATTATCGAA
ATTTCCACCAAAAGCAAACG
17660
ermA/TR [18]AACTTGTGGAAATGAGTCAACGG
CAGAATCTACATTAGGCTTAGGG
37560
ermB [18]ATTGGAACAGGTAAAGGGCG
GAACATCTGTGGTATGGCG
44260
fbsB [17]ACAACTGCGGAAATGACCTC
ACGAGCGACGTTGAATTCTT
18660
mefA [18]AGTATCATTAATCACTAGTGC
TTCTTCTGGTACTAAAAGTGG
34550
tetM [19]GTGGAGTACTACATTTACGAG
GAAGCGGATCACTATCTGAG
35950
tetO [19]GCGGAACATTGCATTTGAGGG
CTCTATGGACAACCCGACAGAAG
53850
scpB [17]AGCCATATGCTGCGATCTCT
GGGTTGAACCAAGTGTGCTT
19860
Table 2. Molecular diversity, capsular type, virulence, and resistance genes of 46 S. agalactiae from dairy farms in Paraiba, Brazil, between 2018 and 2022.
Table 2. Molecular diversity, capsular type, virulence, and resistance genes of 46 S. agalactiae from dairy farms in Paraiba, Brazil, between 2018 and 2022.
MunicipalitiesIsolates (n)PulsotypeCapsular
Type
Virulence
Genes
Resistance
Genes
A315IIIcylB, fbsBermB, tetO
A210IIIcylB, fbsBermB, tetO
A212IIIcylB, fbsBermB, tetO
A218IIIcylB, fbsBermB, tetO
A220IIIcylB, fbsBermB, tetO
A225IIIcylB, fbsBermB, tetO
A111IIIcylB, fbsB-
A113IIIcylB, fbsBermB, tetO
A114IIIcylB, fbsBermB, tetO
A116IIIcylB, fbsBermB, tetO
A117IIIcylB, fbsBermB. tetO
A119IIIcylB, fbsBermB, tetO
A121IIIcylB, fbsBermB, tetO
A122IIIcylB, fbsBermB, tetO
B523IacylB, fbsB-
B31IacylB, fbsB-
B33IacylB, fbsB-
B39IacylB, fbsB-
B24IacylB, fbsBtetM
B26IacylB, fbsBtetM
B28IacylB, fbsBtetM
B12IacylB, fbsB-
B15IacylB, fbsBtetM
B124IacylB, fbsB-
C126IVcylB, fbsB, scpBtetM
D17IacylB, fbsB-
A: Areia; B: Barra de Santana; C: Pilões; D: Soledade; -: not detected.
Table 3. Epidemiological, resistome, and virulome features of eight representative isolates of S. agalactiae from dairy farms in Paraiba, Brazil, between 2018 and 2022.
Table 3. Epidemiological, resistome, and virulome features of eight representative isolates of S. agalactiae from dairy farms in Paraiba, Brazil, between 2018 and 2022.
IsolateSequence TypeARGsVirulence GenesPilus IslandIsolates Accession Number
636SLV 91ant6-Ia, ermB, tetObca cfb cspA cylE fbsA fbsB fbsC hylB rib sip pbsP2BJBCPXS000000000.1
65991-bca cfb cspA cylE fbsA fbsB fbsC hylB rib sip pbsP2BJBBEFD000000000.1
67691ant6-Ia, ermB, tetObca cfb cspA cylE fbsA fbsB fbsC hylB rib sip pbsP2BJBANBL000000000.1
69091ant6-Ia, ermB, tetObca cfb cspA cylE fbsA fbsB fbsC hylB rib sip pbsP2BJBANBM000000000.1
765103-bca cfb cspA cylE fbsA fbsB fbsC hylB rib sip pbsP srr12BCP143102.1
782103-bca cfb cspA cylE fbsA fbsB fbsC hylB rib sip pbsP srr12BCP142854.1
790103tetMbca cfb cspA cylE fbsA fbsB fbsC hylB rib sip pbsP srr12BJAYXIU000000000.1
986103-bca cfb cspA cylE fbsA fbsB fbsC hylB rib sip pbsP srr12BCP142853.1
ARGs: antibiotic resistance genes; SLV: single-locus variant; -: absent.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Perez, V.P.; Manieri, F.Z.; Torini, L.R.; Barbosa, C.G.A.; Campioni, F.; Volpato, F.C.Z.; Campana, E.H.; Fernandes, A.C.d.C.; Barth, A.L.; Sousa, E.S.S.; et al. Dairy Farm Streptococcus agalactiae in a Region of Northeast Brazil: Genetic Diversity, Resistome, and Virulome. Pathogens 2026, 15, 128. https://doi.org/10.3390/pathogens15020128

AMA Style

Perez VP, Manieri FZ, Torini LR, Barbosa CGA, Campioni F, Volpato FCZ, Campana EH, Fernandes ACdC, Barth AL, Sousa ESS, et al. Dairy Farm Streptococcus agalactiae in a Region of Northeast Brazil: Genetic Diversity, Resistome, and Virulome. Pathogens. 2026; 15(2):128. https://doi.org/10.3390/pathogens15020128

Chicago/Turabian Style

Perez, Vinicius Pietta, Fernanda Zani Manieri, Luciana Roberta Torini, Carlos Gabriel Andrade Barbosa, Fabio Campioni, Fabiana Caroline Zempulski Volpato, Eloíza Helena Campana, Artur Cezar de Carvalho Fernandes, Afonso Luís Barth, Eduardo Sergio Soares Sousa, and et al. 2026. "Dairy Farm Streptococcus agalactiae in a Region of Northeast Brazil: Genetic Diversity, Resistome, and Virulome" Pathogens 15, no. 2: 128. https://doi.org/10.3390/pathogens15020128

APA Style

Perez, V. P., Manieri, F. Z., Torini, L. R., Barbosa, C. G. A., Campioni, F., Volpato, F. C. Z., Campana, E. H., Fernandes, A. C. d. C., Barth, A. L., Sousa, E. S. S., de Oliveira, C. J. B., & Camargo, I. L. B. d. C. (2026). Dairy Farm Streptococcus agalactiae in a Region of Northeast Brazil: Genetic Diversity, Resistome, and Virulome. Pathogens, 15(2), 128. https://doi.org/10.3390/pathogens15020128

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop